Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lexicon Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −1 vs. Q4 2022
- Shares held
- 145.6M
- −1.28M (−0.9%) vs. Q4 2022
- Total value
- $353.8M
- +$73.3M (+26.1%) vs. Q4 2022
- New holders
- 14
- 37 more added
- Sold out
- 15
- 34 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 149 | $875.1M |
| Q1 2026 | 137 | $504.5M |
| Q4 2025 | 126 | $299.5M |
| Q3 2025 | 124 | $344.4M |
| Q2 2025 | 123 | $242.9M |
| Q1 2025 | 127 | $122.5M |
| Q4 2024 | 127 | $220.1M |
| Q3 2024 | 137 | $453.1M |
| Q2 2024 | 127 | $471.0M |
| Q1 2024 | 118 | $417.8M |
| Q4 2023 | 106 | $279.8M |
| Q3 2023 | 112 | $205.8M |
| Q2 2023 | 123 | $438.2M |
| Q1 2023 | 104 | $353.8M |
| Q4 2022 | 105 | $280.5M |
| Q3 2022 | 98 | $357.3M |
| Q2 2022 | 86 | $221.0M |
| Q1 2022 | 101 | $251.3M |
| Q4 2021 | 110 | $478.9M |
| Q3 2021 | 96 | $583.0M |
| Q2 2021 | 107 | $540.2M |
| Q1 2021 | 107 | $711.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lexicon Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 5,299,380 | $12.9M | 0.00% | +43,032+0.8% | Added |
| BlackRock Inc. | 5,656,927 | $13.7M | 0.00% | −195,558−3.3% | Reduced |
| BVF Inc | 16,149,179 | $39.2M | 1.43% | 00.0% | Unchanged |
| Artal Group S.A. | 89,778,234 | $218.2M | 12.96% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −115,231−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −47,014−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −46,281−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −38,377−100.0% | Sold out |
| Acrisure Capital Management, LLC | 0 | $0 | 0.00% | −16,861−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −8,160−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −5,167−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Farmers & Merchants Investments Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Hall Laurie J Trustee | 0 | $0 | 0.00% | −720−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Strengthening Families & Communities, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |